Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Iohexol

&times

Overview

What is ORALTAG?

Oraltag (iohexol) is a radiographic contrast agent for oral solution. Oraltag is provided as a nonsterile white to off-white powder with 9.7 g iohexol (equivalent to 4.5 g of carbon bound iodine) in a 20-ounce beverage bottle. Each bottle is individually sealed in a foil laminated pouch. Oraltag consists of 100 percent iohexol and contains no excipients.

Iohexol is designated chemically as N,N´-bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide. It is a nonionic, water-soluble iodinated contrast medium with a molecular weight of 821.14 (carbon bound iodine content 46.36%). In aqueous solution each triiodinated molecule remains undissociated.

The chemical structure is:

Oraltag, when prepared at a concentration of 9 mgI/mL in water, has an osmolality of 30 mOsmol/kg water. The calculated osmolality of 21 mgI/mL in water is 55 mOsmol/kg water. The prepared solutions are hypotonic.



What does ORALTAG look like?



What are the available doses of ORALTAG?

For oral solution: Each single use bottle contains 9.7 g iohexol (equivalent to 4.5 g carbon bound iodine)

What should I talk to my health care provider before I take ORALTAG?

How should I use ORALTAG?

Oraltag is indicated for use in computed tomography of the abdomen and pelvis to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology.

Limitations of Use

Oraltag is not indicated for diagnostic examination of the gastrointestinal tract.


What interacts with ORALTAG?

Sorry No Records found


What are the warnings of ORALTAG?

Sorry No Records found


What are the precautions of ORALTAG?

Sorry No Records found


What are the side effects of ORALTAG?

Sorry No records found


What should I look out for while using ORALTAG?

Oraltag is contraindicated in patients with a known hypersensitivity to iodinated contrast agents, including iohexol .


What might happen if I take too much ORALTAG?

Sorry No Records found


How should I store and handle ORALTAG?

Topiramate tablets should be stored in tightly-closed containers at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from moisture. How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.How SuppliedOraltag is supplied as a nonsterile white to off-white powder for oral solution in a single-use 20-ounce polyethylene terephthalate beverage bottle closed with a lined polypropylene cap. Each bottle is packaged in a sealed foil pouch.Twelve (12) bottles per pack (NDC 54702-501-52).Twenty-five (25) bottles per pack (NDC 54702-501-62).StorageStore at controlled room temperature, 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].Protect prepared solutions of Oraltag from strong daylight and direct exposure to sunlight.Do not use if tamper-evident foil pouch has been opened.


&times

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Iohexol enhances imaging due to its high iodine content attenuating the beam of X-rays during CT examinations. Different tissues within the body attenuate X-rays to different degrees, and oral administration of iohexol allows for enhanced visualization due to the iodine present in bowel loops.

Non-Clinical Toxicology
Oraltag is contraindicated in patients with a known hypersensitivity to iodinated contrast agents, including iohexol .

The following adverse reactions are described in greater detail in other sections:

&times

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

&times

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
&times

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
&times

Tips

Tips

&times

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).